Alvimopan
Back to searchMolecule Structure
Scientific Name
Alvimopan
Description of the Drug
Alvimopan is an opioid antagonist used to reduce healing time of the upper and lower gastrointestinal tract following surgical procedures that involve bowel resection with primary anastomosis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06274
http://www.drugbank.ca/drugs/DB06274
Brand Name(s)
Entereg
Company Owner(s)
Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc, Cubist Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Mu opioid receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL233 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL49578 | ||
| PharmGKB | PA164754864 | ||
| Human Metabolome Database | HMDB0015631 | ||
| DrugBank | DB06274 | ||
| PubChem: Thomson Pharma | 14782746 | 14929630 | |
| PubChem | 51397022 | 5488548 | |
| LINCS | LSM-45414 | ||
| Nikkaji | J605.686E | ||
| PDBe | NG0 | ||
| BindingDB | 50088381 | ||
| EPA CompTox Dashboard | DTXSID60166035 | ||
| DrugCentral | 143 | ||
| Guide to Pharmacology | 7471 | ||
| rxnorm | ALVIMOPAN ANHYDROUS | ENTEREG | ALVIMOPAN |
| ChEBI | 135686 | ||
| ZINC | ZINC000003802417 |
